Companion Diagnostics Market worth $9.9 billion by 2026

Key Facts

The assays, kits & reagents segment accounted for the largest share of the companion diagnostics market, by product & service segment, in 2020 The companion diagnostics market is segmented into assays, kits & reagents, and software & services.
The assays, kits & reagents accounted for the largest share of the companion diagnostics market in 2020, mainly due to the availability of a wide range of products and increasing use of assays and kits in different therapeutic areas.
PCR segment to register the highest growth rate during the forecast period The companion diagnostics market is segmented into polymerase chain reaction (PCR), next-generation sequencing (NGS), in situ hybridization (ISH), immunohistochemistry (IHC), and other technologies.
The pharmaceutical & biotechnology companies segment accounted for the largest share of the companion diagnostics market, by end user segment, in 2020 Based on end user, the companion diagnostics market is segmented into pharmaceutical & biotechnology companies, reference laboratories, CROs, and other end users (including physician & hospital laboratories, and academic medical centers).